Drug prevents bone loss in prostate cancer
Tuesday, July 15th, 2008 Posted in prostate cancer | No Comments »In a study, Amgen Inc's experimental drug Denosumab reduced the risk of osteoporosis and fracture in men being treated with prostate cancer medicines that can cause bone loss, the company said on Monday. But investors remain focused on upcoming data that ...